CSX and BRS Reach Agreement on Paid Sick Leave

Go back to CSX and BRS Reach Agreement on Paid Sick Leave

CSX (CSX) Mentioned Positively at Argus Research, 'weakness offers buying opportunity'

October 23, 2023 8:32 AM EDT

Argus analyst John Eade reiterated a Buy rating and $37.00 price target on CSX (NASDAQ: CSX).

The analyst comments "Our rating on CSX Corp. (NYSE: CSX) is BUY. CSX is among the most efficient operators in... More